Allogene Therapeutics, Inc. - ALLO

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 4/29/2025 10:06:56 PM
EDGAR CIK 0001737287

Buy Breakdown

Total $0

Sell Breakdown

Total $317,270

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
04/21/2025
04/23/2025
Yoshiyama Annie
SVP, Finance
Officer
Sell
-9,601 @ $1.41
($13,537.41)
 130,663 (-6.84%) Direct
03/14/2025
03/18/2025
Beneski Benjamin Machinas
SVP, Chief Technical Officer
Officer
Sell
-5,488 @ $1.98
($10,838.80)
 218,507 (-2.45%) Direct
03/14/2025
03/18/2025
Chang David D
President and CEO
CEO Director
Sell
-46,668 @ $1.96
($91,469.28)
 5,276,569 (-0.88%) Direct
02/03/2025
02/05/2025
Chang David D
President and CEO
CEO Director
Sell
-46,003 @ $1.68
($77,285.04)
 5,317,237 (-0.86%) Direct
02/03/2025
02/05/2025
Douglas Earl Martin
SVP, General Counsel
Officer
Sell
-6,404 @ $1.71
($10,950.84)
 587,848 (-1.08%) Direct
02/03/2025
02/05/2025
Moore Timothy L.
Chief Technical Officer
Officer
Sell
-14,746 @ $1.71
($25,215.66)
 250,713 (-5.55%) Direct
02/03/2025
02/05/2025
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
CFO
Sell
-4,361 @ $1.73
($7,544.53)
 1,301,540 (-0.33%) Direct
02/03/2025
02/05/2025
Roberts Zachary
EVP of R&D
Officer
Sell
-18,832 @ $1.70
($32,014.40)
 643,135 (-2.84%) Direct
01/21/2025
01/23/2025
Roberts Zachary
EVP of R&D
Officer
Sell
-27,199 @ $1.78
($48,414.22)
 488,054 (-5.28%) Direct